Last reviewed · How we verify

NCT04832646: VOLT-AF

VOLTage Mapping in Atrial Fibrillation

Status unknown Last updated 6 April 2021
What this trial tests

trial testing atrial fibrillation ablation in Atrial Fibrillation, Persistent in 30 participants. Status unknown.

Timeline
1 April 2021
Primary endpoint
1 April 2022
1 April 2022

Quick facts

Lead sponsorCentral Hospital, Nancy, France
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 April 2021
Primary completion1 April 2022
Estimated completion1 April 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Central Hospital, Nancy, France

Who can join

Eligibility, any sex, with Atrial Fibrillation, Persistent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to retrospectively analyze electroanatomical data collected during persistent atrial fibrillation ablation procedures, combined with pre-ablation cardiac CT data, in order to: * define a new method for quantifying left atrial voltage in atrial fibrillation via a total energy map instead of a peak-to-peak amplitude map * confirm the association between epicardial fat localization and atrial conduction slowing

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. State of the art paper: Cardiac computed tomography of the left atrium in atrial fibrillation.
    Bodagh N, Williams MC, Vickneson K, Gharaviri A, et al · · 2023 · cited 15× · PMID 36966040 · DOI 10.1016/j.jcct.2023.03.002

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation, Persistent

Currently open trials in the same condition.

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04832646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing